Journal
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
Volume 65, Issue 8, Pages 1574-1581Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jafc.6b05445
Keywords
prenylchalconaringenin; prenylnaringenin; diabetes; alpha-glucosidase; alpha-amylase; docking
Funding
- National Natural Science Foundation of China [21502138]
- Scientific Research Foundation [20110115]
- Laboratory Innovation Foundation of Undergraduate of the Tianjin University of Science and Technology [1504A301]
Ask authors/readers for more resources
Inhibition of alpha-glucosidase and alpha-amylase decreases postprandial blood glucose levels and delays glucose absorption, making it a treatment strategy for type 2 diabetes. This study examined in vivo and in vitro antidiabetic activities of natural prenylchalconaringenins 1 and 2 and prenylnaringenins 3 and 4, found in hops and beer. 3'-Geranylchalconaringenin (2) competitively and irreversibly inhibited alpha-glucosidase (IC50 = 1.08 mu M) with activity 50-fold higher than that of acarbose (IC50 = 51.30 mu M) and showed moderate inhibitory activity against a-amylase (IC50 = 20.46 mu M). Docking analysis substantiated these findings. In addition, compound 2 suppressed the increase in postprandial blood glucose levels and serum levels of total cholesterol and triglycerides in streptozotocin-induced diabetic mice. Taken together, these results suggest that 2 has dual inhibitory activity against alpha-glucosidase and alpha-amylase and alleviates diabetic hyperglycemia and hyperlipidemia, making it a potential functional food ingredient and drug candidate for management of type 2 diabetes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available